IGF1R and neoplasm: Tumor cells may develop drug resistance through various mechanisms, including overexpressing certain proteins (e.g., epidermal growth factor receptor/EGFR, insulin-like growth factor-1 receptor/IGF-1R, c-KIT), which can lead to inhibition of drug efficacy.